Incidence and impact on clinical outcome of infections with piperacillin/tazobactam resistant Escherichia coli in ICU: A retrospective study

BACKGROUND: Escherichia coli infections are frequent in ICU patients. The increased resistance to fluoroquinolones and amoxicillin/clavulanate of this pathogen mandates the prescription of broad-spectrum antibiotics such as piperacillin/tazobactam (PIP-TAZ) or third generation cephalosporins (3GC)....

Descripción completa

Detalles Bibliográficos
Autores principales: Meybeck, Agnès, Ricard, Jean-Damien, Barnaud, Guilène, Eveillard, Mathieu, Chevrel, Guillaume, Mounier, Roman, Dreyfuss, Didier
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409345/
https://www.ncbi.nlm.nih.gov/pubmed/18485230
http://dx.doi.org/10.1186/1471-2334-8-67

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409345/
https://www.ncbi.nlm.nih.gov/pubmed/18485230
http://dx.doi.org/10.1186/1471-2334-8-67

Ejemplares similares